ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$9.46
Tradestie Score
51
Market Cap
$670.30M
Revenue Growth
-0.9%
Analyst Upside
+59.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$120.38
|
$699.30M | - | 56 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.95
|
$688.47M | - | 54 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$10.03
|
$665.30M | - | 58 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$10.25
|
$626.91M | - | 49 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 61 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$26.76
|
$608.81M | - | 60 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.73
|
$552.46M | - | 51 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.80
|
$540.97M | - | 57 | Compare |
More ARVN Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry